| 52-Week High | 1.53 |
|---|---|
| Fibonacci 50% | 1.05 |
| Fibonacci 38.2% | 0.94 |
| Last Price | 0.65 |
| 52-Week Low | 0.57 |
Who are some of Oncobiologics' key competitors?
What other stocks do shareholders of Oncobiologics own?
Some companies that are related to Oncobiologics include Gritstone bio (GRTS), Innate Pharma (IPHA), Innate Pharma (IPHYF), Oyster Point Pharma (OYST), Aerie Pharmaceuticals (AERI), Fusion Pharmaceuticals (FUSN), Opthea (OPT), Taysha Gene Therapies (TSHA), Jounce Therapeutics (JNCE), Cellectis (CLLS), Precision BioSciences (DTIL), Autolus Therapeutics (AUTL), Poseida Therapeutics (PSTX), Cortexyme (CRTX) and Curis (CRIS). View all of ONS's competitors..
What is Oncobiologics' stock price today?
Based on aggregate information from My MarketBeat watchlists, some companies that other Oncobiologics investors own include CRISPR Therapeutics (CRSP), Network-1 Technologies (NTIP), Allena Pharmaceuticals (ALNA), Intra-Cellular Therapies (ITCI), Cidara Therapeutics (CDTX), Neuralstem (CUR), Exelixis (EXEL), Fate Therapeutics (FATE), Ampliphi Biosciences (APHB) and Ardelyx (ARDX)..
How much money does Oncobiologics make?
One share of ONS stock can currently be purchased for approximately $1.28.
How can I contact Oncobiologics?
Oncobiologics has a market capitalization of $92.42 million and generates $3.81 million in revenue each year.
Premium Research for OTLK
Oncobiologics' mailing address is 7 CLARKE DRIVE, CRANBURY NJ, 08512. The company can be reached via phone at (609) 619-3990 or via email at [email protected].
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
